GSK3B and colonic neoplasm: The activation of Akt can trigger many downstream signaling cascades, and in colon cancer PGE2 has been shown to activate Akt and the downstream pathway of GSK-3β and β-catenin resulting in an increased proliferation, whereas an increased survival was due to Akt activation of PPARδ [46], [47].